Please login to the form below

Not currently logged in
Email:
Password:

InnoPharma appoints Deborah DuFresne as VP

Will head strategic portfolio selection and management

Deborah DuFresne has joined InnoPharma as VP, strategic portfolio selection and management.

She joins the US-based company from Impax Laboratories where she was senior director, project management, product identification and development.

DuFresne has also held senior roles at Fera Pharmaceuticals, Sandoz and Apotex.

"Deborah's broad generic and specialty pharmaceutical experience and extensive product knowledge will be vital to InnoPharma as we seek to enhanc our portfolio in a strategic manner,” said InnoPharma's president and CEO Dr Navneet Puri.

“We look forward to working with Deborah as we continue to build our business and execute on our goals."

13th August 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics